These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1282 related items for PubMed ID: 25501045

  • 21. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S, Bennett D, Smith DJ.
    Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
    [Abstract] [Full Text] [Related]

  • 22. The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial Fibrillation.
    Golive A, May HT, Bair TL, Jacobs V, Crandall BG, Cutler MJ, Day JD, Mallender C, Osborn JS, Stevens SM, Weiss JP, Woller SC, Bunch TJ.
    Am J Cardiol; 2017 Jul 01; 120(1):75-82. PubMed ID: 28483209
    [Abstract] [Full Text] [Related]

  • 23. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY, Laroche C, Dan GA, Santini M, Kalarus Z, Rasmussen LH, Ioachim PM, Tica O, Boriani G, Cimaglia P, Diemberger I, Hellum CF, Mortensen B, Maggioni AP.
    Am J Med; 2014 Jun 01; 127(6):519-29.e1. PubMed ID: 24486284
    [Abstract] [Full Text] [Related]

  • 24. The Effect of Bleeding Risk and Frailty Status on Anticoagulation Patterns in Octogenarians With Atrial Fibrillation: The FRAIL-AF Study.
    Lefebvre MC, St-Onge M, Glazer-Cavanagh M, Bell L, Kha Nguyen JN, Viet-Quoc Nguyen P, Tannenbaum C.
    Can J Cardiol; 2016 Feb 01; 32(2):169-76. PubMed ID: 26277091
    [Abstract] [Full Text] [Related]

  • 25. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
    Taillandier S, Olesen JB, Clémenty N, Lagrenade I, Babuty D, Lip GY, Fauchier L.
    J Cardiovasc Electrophysiol; 2012 Jul 01; 23(7):708-13. PubMed ID: 22268375
    [Abstract] [Full Text] [Related]

  • 26. Temporal trends in antithrombotic treatment of real-world UK patients with newly diagnosed atrial fibrillation: findings from the GARFIELD-AF registry.
    Apenteng PN, Gao H, Hobbs FR, Fitzmaurice DA, UK GARFIELD-AF Investigators and GARFIELD-AF Steering Committee.
    BMJ Open; 2018 Jan 13; 8(1):e018905. PubMed ID: 29331969
    [Abstract] [Full Text] [Related]

  • 27. Prevalence, incidence, and lifetime risk of atrial fibrillation in China: new insights into the global burden of atrial fibrillation.
    Guo Y, Tian Y, Wang H, Si Q, Wang Y, Lip GYH.
    Chest; 2015 Jan 13; 147(1):109-119. PubMed ID: 24921459
    [Abstract] [Full Text] [Related]

  • 28. [Atrial fibrillation and thromboembolic events prevention. State of the art].
    Matteoli S, Trappolini M, Chillotti FM.
    Minerva Cardioangiol; 2001 Feb 13; 49(1):1-13. PubMed ID: 11279381
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Anticoagulation Control in Warfarin-Treated Patients Undergoing Cardioversion of Atrial Fibrillation (from the Edoxaban Versus Enoxaparin-Warfarin in Patients Undergoing Cardioversion of Atrial Fibrillation Trial).
    Lip GYH, Al-Saady N, Jin J, Sun M, Melino M, Winters SM, Zamoryakhin D, Goette A.
    Am J Cardiol; 2017 Sep 01; 120(5):792-796. PubMed ID: 28709650
    [Abstract] [Full Text] [Related]

  • 31. Increased risk of first-ever stroke in younger patients with atrial fibrillation not recommended for antithrombotic therapy by current guidelines: a population-based study in an East Asian cohort of 22 million people.
    Chang KC, Wang YC, Ko PY, Wu HP, Chen YW, Muo CH, Sung FC, Li TC, Hsu CY.
    Mayo Clin Proc; 2014 Nov 01; 89(11):1487-97. PubMed ID: 25444485
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report.
    Lip GYH, Banerjee A, Boriani G, Chiang CE, Fargo R, Freedman B, Lane DA, Ruff CT, Turakhia M, Werring D, Patel S, Moores L.
    Chest; 2018 Nov 01; 154(5):1121-1201. PubMed ID: 30144419
    [Abstract] [Full Text] [Related]

  • 35. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?
    Go AS, Hylek EM, Chang Y, Phillips KA, Henault LE, Capra AM, Jensvold NG, Selby JV, Singer DE.
    JAMA; 2003 Nov 26; 290(20):2685-92. PubMed ID: 14645310
    [Abstract] [Full Text] [Related]

  • 36. Reviewing a clinical decision aid for the selection of anticoagulation treatment in patients with nonvalvular atrial fibrillation: applications in a US managed care health plan database.
    Deitelzweig SB, Jing Y, Swindle JP, Makenbaeva D.
    Clin Ther; 2014 Nov 01; 36(11):1566-1573.e3. PubMed ID: 25438725
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation.
    Gulløv AL, Koefoed BG, Petersen P.
    Arch Intern Med; 1999 Jun 28; 159(12):1322-8. PubMed ID: 10386508
    [Abstract] [Full Text] [Related]

  • 39. Risk of stroke and intracranial hemorrhage in 9727 Chinese with atrial fibrillation in Hong Kong.
    Siu CW, Lip GY, Lam KF, Tse HF.
    Heart Rhythm; 2014 Aug 28; 11(8):1401-8. PubMed ID: 24747420
    [Abstract] [Full Text] [Related]

  • 40. Guidelines for stroke prevention in patients with atrial fibrillation.
    Howard PA.
    Drugs; 1999 Dec 28; 58(6):997-1009. PubMed ID: 10651387
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 65.